Omalizumab and dupilumab for the treatment of autosomal-recessive DOCK8 hyper-IgE syndrome

Indian J Dermatol Venereol Leprol. 2023 Oct 17:1-3. doi: 10.25259/IJDVL_348_2023. Online ahead of print.

Authors

Ting Guo¹, Lili Wei¹, Saroj Karki¹, Sijian Wen¹, Qiuju Li¹, Youkun Lin¹

Affiliation

¹ Department of Dermatology and Venereology, The first affiliated Hospital of Guangxi Medical University, Guangxi, China.

PMID: 38031685
DOI: 10.25259/IJDVL_348_2023

No abstract available

Publication types

Letter